Pneumonia Testing companies

  • Report ID: 4457
  • Published Date: Aug 19, 2025
  • Report Format: PDF, PPT

Key Pneumonia Testing Market Players:

    The international pneumonia testing market is extremely dominated with key players, including Thermo Fisher, Abbott, and Roche, combinedly leveraging POC and PCR advancements to effectively maintain a joint market share. In addition, diagnostic investment, rapid test implementation are suitable strategies that these organizations have integrated for boosting the overall market. Besides, Fujirebio and Sysmex are successfully leading automation, along with ELISA testing, to deliberately focus on the regional aging population. Besides, Siemens, BioMérieux, and QuidelOrtho have readily integrated AI, multiple panels, and telemedicine to uplift the market across different nations.

    Here is a list of key players operating in the global market:

    Company Name (Country)

    Industry Focus

    Market Share (2024)

    Roche Diagnostics (Switzerland)

    Leading molecular diagnostics (Cobas PCR systems, Liat POC platform)

    18.6%

    Abbott Laboratories (U.S.)

    Rapid tests (BinaxNOW), PCR panels (Alinity m)

    15.8%

    Thermo Fisher Scientific (U.S.)

    Gold-standard PCR kits (TaqPath), automated systems

    12.5%

    BioMérieux (France)

    Culture-based diagnostics (VITEK), syndromic panels (BioFire)

    10.7%

    BD (Becton Dickinson) (U.S.)

    Automated platforms (BD MAX), rapid antigen tests

    8.2%

    Siemens Healthineers (Germany)

    AI-driven diagnostics (Atellica), lab automation

    xx%

    QuidelOrtho (U.S.)

    Rapid POC tests (Sofia), multiplex PCR (Savanna)

    xx%

    Danaher (U.S.)

    Cepheid’s Xpert Xpress PCR, Luminex multiplex assays

    xx%

    Qiagen (Germany)

    Sample prep (QIAstat-Dx), syndromic testing

    xx%

    Bio-Rad Laboratories (U.S.)

    Droplet Digital PCR (ddPCR), serology tests

    xx%

    Sysmex (South Korea)

    Hematology analyzers repurposed for pneumonia detection

    xx%

    Trivitron Healthcare (India)

    Low-cost rapid tests, OEM manufacturing

    xx%

    SD Biosensor (South Korea)

    STANDARD Q COVID/pneumonia combo tests

    xx%

    Tulip Diagnostics (India)

    Rapid immunochromatographic tests for rural use

    xx%

    ACON Laboratories (U.S.)

    Flowflex rapid antigen tests for emerging markets

    xx%

    Sources: Roche, Abbott, Thermo Fisher, BioMérieux, BD Global, Siemens Health, QuidelOrtho, Danaher, Qiagen, Bio-Rad, Sysmex Korea, Trivitron, SD Biosensor, Tulip, ACON, Sysmex Japan, Fujirebio, LSI Medience, Eiken, Tosoh

    Below are the areas covered for each company in the pneumonia testing market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of the pneumonia testing market was over USD 2.5 billion.

The market size for the pneumonia testing market is projected to reach USD 4.6 billion by the end of 2035 expanding at a CAGR of 7.2% during the forecast period i.e., between 2026-2035.

The major players in the market are Roche, Abbott, Thermo Fisher, BioMérieux, BD Global, and others.

In terms of the end user segment, the hospitals and clinics segment is anticipated to garner the largest market share of 45.8% by 2035 and display lucrative growth opportunities during 2026-2035.

The market in North America is projected to hold the largest market share of 38.3% by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos